German Federal Joint Committee (G-BA)

On March 2, 2023, the Innovation Committee at the Federal Joint Committee (G-BA) published the determined funding priorities for new forms of care. A total of six prioritized topics are defined. The preparation of a complete application can be supported for a period of up to six months with a grant of up to a maximum of €75,000. The deadline for submitting ideas is May 16, 2023.

On February 23, 2023, the Innovation Committee at the Federal Joint Committee (G-BA) published the decisions, recommending the transfer to standard care for another three completed projects. The projects relate to preventing the family risk of colorectal carcinoma, shared decision-making in the hospitals, and digitally supported drug therapy management.

On January 25, 2023, the Innovation Committee at the Federal Joint Committee (G-BA) published the decisions, recommending the transfer to standard care for another two completed projects. The projects relate to the improvement of the management of peripheral arterial occlusive disease (PAD) patients and the aftercare of pediatric patients suffering from chronic pain.

On January 3, 2023, the Federal Joint Committee (G-BA) initiated the evaluation procedure concerning the method of renal denervation using ultrasound ablation in treatment-resistant hypertension (Paradise-System™ by ReCor Medical) within the framework of the early benefit assessment (in line with § 137h SGB V).

On November 18, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) announced the selection of twenty-eight project ideas for Innovation Funding of the new forms of care within the framework of the two-stage application process. A total of 114 project ideas were received in response to the funding announcement of March 3, 2022, and only twenty-eight were accepted.

On November 18, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) announced that sixteen applications for Innovation Funding of the new forms of care were accepted. These applications relate to the funding announcement of March 17, 2021. Most projects relate to interdisciplinary or cross-sectoral care and pathways.

On October 28, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) reported that 231 applications were received for innovation funding of healthcare research projects.

On October 17, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) published the decision, recommending the transfer to standard care for another completed project. The project relates to the improvement of the management of cancer patients.

On July 14, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) published the decisions, recommending the transfer to standard care for two completed projects. The projects relate to the improvement of sepsis management.

On June 27, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) published the determined funding priorities for healthcare research projects (seven topics) and clinical guidelines (four topics).

On June 24, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) published the decisions, recommending the transfer to standard care for two completed projects. The projects relate to preventing delirium, postoperative cognitive dysfunction, and back pain therapy using e-health.

On June 7, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) published the overview of the 32 innovative healthcare research projects that will be funded, including those belonging to the eHealth technology group.